FSD Pharma [NASDAQ: HUGE] Decides To File IND For FSD201 To Treat COVID-19 Patients
FSD Pharma Inc. [NASDAQ: HUGE] has submitted an Investigational New Drug (IND) application to the US Food and Drug Administration (FDA) to gain approval for
FSD Pharma Inc. [NASDAQ: HUGE] has submitted an Investigational New Drug (IND) application to the US Food and Drug Administration (FDA) to gain approval for
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.